39 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
to the date the milestone was met and paid $2.3 million in cash in satisfaction of the Phase 3 navacaprant milestone to the former equity holders
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
to the satisfaction of the FDA or any comparable foreign regulatory authority that the applicable product candidate is safe and effective as for its intended uses;
our … ability to demonstrate to the satisfaction of the FDA or any comparable foreign regulatory authority that the applicable product candidate’s risk
S-8
EX-99.1
NMRA
Neumora Therapeutics Inc.
19 Sep 23
Registration of securities for employees
9:57pm
or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer … be resold,
B-1-1
subject to the satisfaction of certain of the conditions specified by Rule 144, including: (1) the resale being made through
S-8
EX-99.3
0r677nx6q7vff6
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.1
26slttryb geum
19 Sep 23
Registration of securities for employees
9:57pm
424B4
hljs0
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
EX-1.1
88x1nkk2x sh8aa
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
he7qp0ogt 4wfot65
11 Sep 23
IPO registration (amended)
6:07am
S-1
wuvjeh3pp
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
44gclxi32
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.1
ywt182e5sonkew la8yz
25 Aug 23
IPO registration
5:03pm
S-1
EX-3.1
qe5fb 3ka0j
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.6
lejb7d
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
99b scsnq
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.6
r7brn9w67fql87rl
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.7
b5peb3tefbzh0 qtykc
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.14
0mtxkfwom 3qmga
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
lvxxze6
25 Aug 23
IPO registration
5:03pm